Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Momenta Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: DewDiligence_on_SI who wrote (2594)	11/2/2010 3:45:04 PM
From: Jeffry K. Smith	Read Replies (1) \| Respond to of 3027

Dew, I've been watching the back and forth on iHub about TEVA's "claims", or whatever you want to call their characterizations - basically that their generic enoxoparin is close to approval. The latest is that they've moved to "we know" from "we believe". I've only been in MNTA for six months or so, so what appears to be LOTS and LOTS of word games is new to me... and getting disconcerting. Does your experience tell you that this stuff is more of the same, or are you a little bit more cautious after TEVA's statements today? Thanks for your input. (and for your insights, which made me buy some MNTA in the first place!)